CMS OKs new payment code for outpatient remdesivir administration

CMS approved a new payment code for the administration of remdesivir, an antiviral drug authorized to treat COVID-19, in an outpatient setting.

Advertisement

The approved Healthcare Common Procedure Coding System code is J0248 for administration of Veklury, the brand name of Gilead Sciences’ remdesivir.

The payment code could be used for dates of service on or after Dec. 23, 2021.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.